These products are designed to help athletes improve performance, support recovery and optimize overall health
The future of diabetes and obesity management looks incredibly promising with these advancements, creating a new era of metabolic health
In India, the launch of Wegovy in June 2025 underscores the growing demand for injectable anti-obesity treatments
Gut microbiota DPP4-like enzymes are increased in type-2 diabetes and contribute to incretin inactivation
A search of the trial literature and registries finds retatrutide studied in obesity, in type 2 diabetes, in MASLD, in knee osteoarthritis with obesity, and in cardiovascular-disease populations but not in a cohort defined by PCOS, and not with PCOS-specific reproductive or androgen endpoints
If you miss a dose, follow the instructions provided in the Patient Information Leaflet or contact your pharmacist or prescribing clinician for advice